Welcome to our dedicated page for SELECT MEDICAL HOLDINGS SEC filings (Ticker: SEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Select Medical Holdings Corporation SEC filings document the formal disclosures of a NYSE-listed healthcare services company with common stock traded under SEM. Its Form 8-K reports cover operating results and financial condition, material-event disclosures, capital-structure information, employment and compensation-related agreements, and Regulation FD communications.
Proxy materials and annual-meeting filings describe director elections, executive compensation votes, auditor ratification, board-structure proposals, stockholder meeting rights and voting outcomes. The filings also record governance matters and corporate reporting related to Select Medical's hospital and outpatient rehabilitation operations.
Insider activity: Director Thomas Daniel filed Form 4 for Select Medical Holdings (SEM) disclosing a grant of 14,035 restricted shares on 07/29/2025 (transaction code “A”). The award carries a $0 purchase price and vests in full on 07/29/2026. Following the grant, Daniel directly owns 80,035 common shares; no derivative securities or sales were reported.
The filing represents routine director compensation and modestly increases insider ownership. No cash outlay, option exercises or open-market purchases occurred, so the transaction is unlikely to materially affect near-term supply-demand dynamics for SEM shares.